Literature DB >> 9366561

Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation.

R Sehmi1, L J Wood, R Watson, R Foley, Q Hamid, P M O'Byrne, J A Denburg.   

Abstract

We have proposed previously that hemopoietic myeloid progenitors contribute to the ongoing recruitment of proinflammatory cells, namely eosinophils, to sites of allergen challenge in allergic diseases such as asthma. In this study, we investigated the involvement of bone marrow-derived progenitors in the development of allergen-induced pulmonary inflammation in mild asthmatic subjects. By flow cytometry, we enumerated the level of expression of CD34, a hemopoietic progenitor cell marker, on bone marrow aspirates taken before and 24 h after allergen challenge. In addition, the coexpression of the alpha-subunits of IL-3 receptor (IL-3R) and IL-5 receptor (IL-5R) on CD34+ cells was investigated. After allergen-challenge, although no significant change in total BM CD34+ cell numbers was observed, a significant increase in the proportion of CD34+ cells expressing IL-5R alpha, but not IL-3R alpha, was detected in the 24-h post-allergen, compared with the pre-allergen bone marrow. This was associated with a significant blood and sputum eosinophilia and increased methacholine airway responsiveness, 24 h post-allergen. Using simultaneous in situ hybridization and immunocytochemistry, we colocalized the expression of messenger RNA for membrane-bound IL-5R alpha to CD34+ cells. In summary, our data suggest that increased expression of IL-5R alpha on CD34+ cells favors eosinophilopoiesis and may thus contribute to the subsequent development of blood and tissue eosinophilia, a hallmark of allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366561      PMCID: PMC508447          DOI: 10.1172/JCI119789

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering.

Authors:  D R Sutherland; L Anderson; M Keeney; R Nayar; I Chin-Yee
Journal:  J Hematother       Date:  1996-06

2.  Allergen-induced increase in bone marrow progenitors in airway hyperresponsive dogs: regulation by a serum hemopoietic factor.

Authors:  M D Inman; J A Denburg; R Ellis; M Dahlback; P M O'Byrne
Journal:  Am J Respir Cell Mol Biol       Date:  1996-09       Impact factor: 6.914

3.  Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects.

Authors:  R Sehmi; K Howie; D R Sutherland; W Schragge; P M O'Byrne; J A Denburg
Journal:  Am J Respir Cell Mol Biol       Date:  1996-11       Impact factor: 6.914

4.  Target cells for granulocyte colony-stimulating factor, interleukin-3, and interleukin-5 in differentiation pathways of neutrophils and eosinophils.

Authors:  H Ema; T Suda; K Nagayoshi; Y Miura; C I Civin; H Nakauchi
Journal:  Blood       Date:  1990-11-15       Impact factor: 22.113

Review 5.  Inhibition of pulmonary eosinophilia and hyperreactivity by antibodies to interleukin-5.

Authors:  R W Egan; D Athwahl; C C Chou; S Emtage; C H Jehn; T T Kung; P J Mauser; N J Murgolo; M W Bodmer
Journal:  Int Arch Allergy Immunol       Date:  1995 May-Jun       Impact factor: 2.749

6.  Changing the differentiation program of hematopoietic cells: retinoic acid-induced shift of eosinophil-committed cells to neutrophils.

Authors:  C C Paul; S Mahrer; M Tolbert; B L Elbert; I Wong; S J Ackerman; M A Baumann
Journal:  Blood       Date:  1995-11-15       Impact factor: 22.113

7.  Differential expression of granulocyte-macrophage colony-stimulating factor and IL-3 receptor subunits on human CD34+ cells and leukemic cell lines.

Authors:  H Kurata; T Arai; T Yokota; K Arai
Journal:  J Allergy Clin Immunol       Date:  1995-12       Impact factor: 10.793

8.  Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody.

Authors:  T T Kung; D M Stelts; J A Zurcher; G K Adams; R W Egan; W Kreutner; A S Watnick; H Jones; R W Chapman
Journal:  Am J Respir Cell Mol Biol       Date:  1995-09       Impact factor: 6.914

9.  Effects of an antibody to interleukin-5 in a monkey model of asthma.

Authors:  P J Mauser; A M Pitman; X Fernandez; S K Foran; G K Adams; W Kreutner; R W Egan; R W Chapman
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

10.  Eosinophilia in transgenic mice expressing interleukin 5.

Authors:  L A Dent; M Strath; A L Mellor; C J Sanderson
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

View more
  46 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  Haemopoietic mechanisms in nasal polyposis and asthma.

Authors:  J A Denburg
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

3.  Local proliferation and mobilization of CCR3(+)  CD34(+) eosinophil-lineage-committed cells in the lung.

Authors:  Madeleine Rådinger; Apostolos Bossios; Margareta Sjöstrand; You Lu; Carina Malmhäll; Anna-Karin Dahlborn; James J Lee; Jan Lötvall
Journal:  Immunology       Date:  2010-09-28       Impact factor: 7.397

Review 4.  Understanding allergic asthma from allergen inhalation tests.

Authors:  Donald W Cockcroft; Fredrick E Hargreave; Paul M O'Byrne; Louis-Philippe Boulet
Journal:  Can Respir J       Date:  2007-10       Impact factor: 2.409

5.  Characterization of the phenotype of human eosinophils and their progenitors in the bone marrow of healthy individuals.

Authors:  Marwan Hassani; Selma van Staveren; Erinke van Grinsven; Marije Bartels; Kiki Tesselaar; Guus Leijte; Matthijs Kox; Peter Pickkers; Nienke Vrisekoop; Leo Koenderman
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

6.  Association of FANCC polymorphisms with FEV1 decline in aspirin exacerbated respiratory disease.

Authors:  Jeong-Hyun Kim; Byung-Lae Park; Charisse Flerida A Pasaje; Joon Seol Bae; Jong Sook Park; Sung Woo Park; Soo-Taek Uh; Jae-Sung Choi; Yong-Hoon Kim; Mi-Kyeong Kim; Inseon S Choi; Sang Heon Cho; Byoung Whui Choi; Choon-Sik Park; Hyoung Doo Shin
Journal:  Mol Biol Rep       Date:  2011-06-14       Impact factor: 2.316

7.  Haemopoietic mechanisms in murine allergic upper and lower airway inflammation.

Authors:  Jing Li; Hiroko Saito; Lynn Crawford; Mark D Inman; Michael M Cyr; Judah A Denburg
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

Review 8.  In situ hematopoiesis: a regulator of TH2 cytokine-mediated immunity and inflammation at mucosal surfaces.

Authors:  C C K Hui; K M McNagny; J A Denburg; M C Siracusa
Journal:  Mucosal Immunol       Date:  2015-03-18       Impact factor: 7.313

Review 9.  The pharmacological modulation of allergen-induced asthma.

Authors:  L L Ma; Paul M O'Byrne
Journal:  Inflammopharmacology       Date:  2012-10-25       Impact factor: 4.473

10.  Relationship between Asthma and Rhinitis: Epidemiologic, Pathophysiologic, and Therapeutic Aspects.

Authors:  Celine Bergeron; Qutayba Hamid
Journal:  Allergy Asthma Clin Immunol       Date:  2005-06-15       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.